基本信息:
- 专利标题: PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
- 申请号:PCT/US2020/066104 申请日:2020-12-18
- 公开(公告)号:WO2021127499A1 公开(公告)日:2021-06-24
- 发明人: FARNEY, Elliot, P. , SHIROODI, Roohollah, Kazem , XIONG, Zhaoming , ZHANG, Qingwei , O'CONNOR, Matthew , HALVORSEN, Geoff, T. , ZHAO, Hongyu , BAUMGARTNER, Christina , FROST, Jennifer, M. , KYM, Philip, R. , ABBOTT, Jason, R. , BOGDAN, Andrew , ECONOMOU, Christos , WANG, Xueqing
- 申请人: CALICO LIFE SCIENCES LLC , ABBVIE INC.
- 申请人地址: 1170 Veterans Blvd.; 1 North Waukegan Road
- 专利权人: CALICO LIFE SCIENCES LLC,ABBVIE INC.
- 当前专利权人: CALICO LIFE SCIENCES LLC,ABBVIE INC.
- 当前专利权人地址: 1170 Veterans Blvd.; 1 North Waukegan Road
- 代理机构: CAI, Yingying et al.
- 优先权: US62/949,613 2019-12-18
- 主分类号: C07D285/10
- IPC分类号: C07D285/10 ; C07D417/04 ; C07D417/10 ; C07D417/12 ; A61K31/433 ; A61K31/5377 ; A61K31/4523 ; A61K31/4427 ; A61P3/00 ; A61P35/00 ; C07F9/00 ; C07F9/65397 ; C07F9/65583 ; C07F9/65586
摘要:
Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g, protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g, a cancer or a metabolic disease.
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07D | 杂环化合物 |
------C07D285/00 | 杂环化合物,有氮原子和硫原子作为仅有的杂环原子的环,不包含在C07D275/00至C07D283/00组中 |
--------C07D285/01 | .五元环 |
----------C07D285/02 | ..噻二唑;氢化噻二唑 |
------------C07D285/04 | ...不和其他环稠合 |
--------------C07D285/10 | ....1,2,5-噻二唑;氢化1,2,5-噻二唑 |